Showing results (951-960 of 2,578) with videos related to
Sort By:
Pageof 258
Molecular Oncology|July 21, 2021
Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindranceAntonia Piazzesi, Sumaiya Yasmeen Afsar, Gerhild van Echten-DeckertMolecular Oncology|May 27, 2022
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancersMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.Molecular Oncology|May 20, 2022
Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancerAnne-Sophie Hatat, Clara Benoit-Pilven, Amélie Pucciarelli, et al.Molecular Oncology|May 20, 2022
NNK from tobacco smoking enhances pancreatic cancer cell stemness and chemoresistance by creating a β2AR-Akt feedback loop that activates autophagyXin Chen, Weifan Zhang, Rujuan Liu, et al.Molecular Oncology|July 4, 2021
LAMC1 upregulation via TGFβ induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-κB-CXCL1-STAT3Lingling Fang, Yun Che, Chaoqi Zhang, et al.Molecular Oncology|January 7, 2021
Kinome inhibition reveals a role for polo-like kinase 1 in targeting post-transcriptional control in cancerQamraa H Al-Qahtani, Walid N Moghrabi, Suhad Al-Yahya, et al.Molecular Oncology|January 7, 2021
Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapyXiangyong Li, Chi Zhou, Ke Chen, et al.Molecular Oncology|January 9, 2021
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemiaMyint Myat Khine Aung, Megan L Mills, Joana Bittencourt-Silvestre, et al.Molecular Oncology|May 31, 2021
Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinasesEsther P Jane, Daniel R Premkumar, Dhivyaa Rajasundaram, et al.Molecular Oncology|June 1, 2021
Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancerYi Ding, Vera Labitzky, Karen Legler, et al.Pageof 258